Form 8-K - Current report:
SEC Accession No. 0001477932-24-001846
Filing Date
2024-04-03
Accepted
2024-04-03 16:15:38
Documents
15
Period of Report
2024-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bicx_8k.htm   iXBRL 8-K 22192
  Complete submission text file 0001477932-24-001846.txt   135277

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bicx-20240329.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bicx-20240329_lab.xml EX-101.LAB 13171
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bicx-20240329_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bicx-20240329_pre.xml EX-101.PRE 8249
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bicx-20240329_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT bicx_8k_htm.xml XML 3539
Mailing Address 2390 EAST ORANGEWOOD AVENUE SUITE 500 ANAHEIM CA 92806
Business Address 2390 EAST ORANGEWOOD AVENUE SUITE 500 ANAHEIM CA 92806 (714) 462-4880
BioCorRx Inc. (Filer) CIK: 0001443863 (see all company filings)

EIN.: 900967447 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54208 | Film No.: 24818901
SIC: 8093 Services-Specialty Outpatient Facilities, NEC
(CF Office: 08 Industrial Applications and Services)